Sullivan
Microsoft has discontinued support for Internet Explorer. To access the Sullivan website, please install a modern browser like Microsoft Edge or Google Chrome.

Biography

Oded is a Partner in the New York office and also serves as Co-Managing Partner of Sullivan's Tel Aviv office. His practice focuses on capital markets. He specializes in counseling public companies on financings and ongoing corporate governance, disclosure and compliance matters. Oded has been involved in numerous public offerings and exchange listings in Wall Street of both private and TASE-listed Israeli companies. He has extensive experience representing New York investment banks in public offerings and private placements. Oded is counsel to several Israeli governmental entities that operate in the U.S. He also guides and assists Israeli start-up companies in their various legal needs while establishing presence in the U.S. Oded has been involved in various public interest activities in Israel and New York.

Education
  • New York University School of Law (LL.B., magna cum laude)
  • New York University School of Law (LL.M.)
  • Leonard N. Stern School of Business at NYU (APCLB)
    • Concentration in Finance
Bar & Court Admissions
  • Israel
  • New York
Professional Qualifications
  • New York Bar Association
  • Israeli Bar Association
Awards & Honors
  • Israel Desks League 2024, Notable Ranking (Capital Markets)
  • The Legal 500 Israel (2020)
  • Chambers Global, Corporate/M&A - Israel (Foreign Expert) (2015, 2016)
  • Recommended by The Legal 500 U.S. (2017, 2021)
Community Engagement
  • Member, Israeli-American Council of New York
  • Member of the Board of Trustees, Beit Rabban Day School
Languages
  • English
  • Hebrew
Viewpoints
All Viewpoints
SEC Stays Approval of Nasdaq’s $5 Million MVLS Continued Listing Requirement Pending Commission Review
On July 29, 2026, the Securities and Exchange Commission (the "SEC") notified Nasdaq that it had received notices of intention to petition for review of the SEC's July 22, 2026 order approving Nasdaq's proposed rule change requiring listed companies to maintain a minimum Market Value of Listed Securities ("MVLS") of $5 million. Pursuant to Rule 431(e) of the SEC's Rules of Practice, the July 22, 2026 approval order has been stayed pending further review. As discussed in our July 23, 2026 client alert, the approved rule established a new continued listing standard applicable to companies listed on the Nasdaq Capital Market, Nasdaq Global Market and Nasdaq Global Select Market. Under the approved rule, issuers that failed to maintain an MVLS of at least $5 million for 30 consecutive business days would become subject to immediate delisting procedures without the benefit of a traditional cure period. The Effect of the Stay The SEC's July 29, 2026 letter does not reverse or vacate the July 22, 2026 approval of the rule. Rather, it temporarily suspends the effectiveness of that order. According to the SEC, the stay will remain in effect "until the Commission orders otherwise." As a result, the implementation of Nasdaq's new $5 million MVLS continued listing requirement is currently on hold. Until the SEC takes further action, market participants should monitor developments regarding the review process and any subsequent order. Practical Considerations for Nasdaq Issuers Despite the stay, Nasdaq-listed companies that may be affected by the proposed MVLS requirement should continue to evaluate their compliance position and consider the potential impact of the rule should it ultimately become effective. In particular, issuers that may be at risk of falling below the proposed $5 million MVLS requirement should closely monitor whether, if the stay is lifted, any period following the July 22, 2026 approval order will count toward the rule's 30 consecutive business day requirement. We will continue to monitor developments and provide updates as additional information becomes available. For More Information If you would like additional information regarding the SEC's stay of Nasdaq's proposed $5 million MVLS continued listing requirement, the ongoing review process, Nasdaq listing standards generally, or the implications of these developments for your company, please contact the Sullivan & Worcester lawyer with whom you regularly work or any of the attorneys listed below. David Danovitch, Partner (New York) | +1 (212) 660-3060 | ddanovitch@sullivanlaw.com Oded Har-Even, Partner (New York and Tel-Aviv) | +1 (212) 660-3063 | ohareven@sullivanlaw.com Howard Berkenblit, Partner (Boston) | +1 (617) 338-2979 | hberkenblit@sullivanlaw.com Angela Gomes, Partner (Boston) | +1 (617) 338-2957 | agomes@sullivanlaw.com Joseph Segilia, Partner (New York) | +1 (212) 660-3027 | jsegilia@sullivanlaw.com Ron Ben-Bassat, Partner (New York) | +1 (212) 660-5003 | rbenbassat@sullivanlaw.com Eric Victorson, Partner (New York) | +1 (212) 660-3092 | evictorson@sullivanlaw.com Brendan O'Brien, Partner (New York) | +1 (212) 660-3013 | bobrien@sullivanlaw.com Phillip Carnevale, Associate (New York) | +1 (212) 660-3002 | pcarnevale@sullivanlaw.com Elizabeth Johnson, Associate (New York) | +1 (212) 660-3006 | ejohnson@sullivanlaw.com This Client Alert is provided for general informational purposes only and does not constitute legal advice.
Sullivan & Worcester Submits Comment to SEC on Foreign Private Issuer Definition
On September 8, 2025, Sullivan & Worcester submitted a comment letter to the U.S. Securities and Exchange Commission (SEC) in response to Release No. 33-11376; File No. S7-2025-01, which seeks public input on the definition of “foreign private issuer” (FPI) and potential reforms to the framework. The letter, authored by Partners Oded Har-Even, Howard Berkenblit and Eric Victorson, with contributions from Associate Ilana Neck Levin, draws on the firm’s extensive experience advising foreign private issuers, particularly Israeli companies, which comprise a significant portion of the U.S.-listed FPI market. Sullivan’s comments emphasize that the Business Contacts Test should remain the central determinant of FPI status. The letter explains that the shareholder test is often unreliable due to incomplete ownership data, volatility in investor residency and its limited alignment with policy objectives. In contrast, the Business Contacts Test, which focuses on where a company’s management, assets and operations are located, provides a consistent, substance-based standard that has served the markets well for decades. The firm noted that putting too much emphasis on shareholder residency or trading activity could wrongly classify genuine foreign companies as U.S. issuers, creating confusion for investors and making it harder for those companies to raise capital. Instead, Sullivan urged the SEC to keep the current framework in place, making only targeted adjustments where there are clear market concerns.
Sullivan Represents Fattal Hotel Group in Acquisition of The Blakely Hotel in Midtown Manhattan
Sullivan & Worcester represented Fattal Hotel Group, owner and operator of 329 hotels across 22 countries and based in Tel Aviv, in its acquisition and financing of The Blakely Hotel in Midtown Manhattan. The acquisition marks the client's first hotel investment in the United States and is a milestone in its evolution from a leading European hospitality operator into a global hotel group. The acquisition was completed on July 7, 2026. The Sullivan team included Ashley Brooks, Tamir Chagal, Oded Har-Even, Gerry Silver, John Steiner, Nancy Gillman and Ashley Tan. Read more about the transaction here.  
Sullivan Advises Inspira Technologies on Strategic $12.5M Acquisition of Nano Dimension’s AME Platform
Sullivan & Worcester represented Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN), a commercial-stage medical device company, in its acquisition of Nano Dimension’s Additive Manufactured Electronics (AME) platform, a multi-material additive manufacturing platform capable of printing 3D electronic layers with micro-scale precision. The transaction is valued at up to $12.5 million, comprising a $2.0 million upfront cash payment and up to $10.5 million of deferred payments tied to the future performance of the platform over the next twelve months. The Sullivan team involved in the transaction included Oded Har-Even, Reut Alfiah, Tamir Chagal, Shemer Sendak, Ron Ben-Bassat and Shiran Soholitsky. Read the full press release here.

Oded Har-Even

Oded is a Partner in the New York office and also serves as Co-Managing Partner of Sullivan's Tel Aviv office. His practice focuses on capital markets. He specializes in counseling public companies on financings and ongoing corporate governance, disclosure and compliance matters. Oded has been involved in numerous public offerings and exchange listings in Wall Street of both private and TASE-listed Israeli companies. He has extensive experience representing New York investment banks in public offerings and private placements. Oded is counsel to several Israeli governmental entities that operate in the U.S. He also guides and assists Israeli start-up companies in their various legal needs while establishing presence in the U.S. Oded has been involved in various public interest activities in Israel and New York.

Viewpoints
All Viewpoints
SEC Stays Approval of Nasdaq’s $5 Million MVLS Continued Listing Requirement Pending Commission Review
On July 29, 2026, the Securities and Exchange Commission (the "SEC") notified Nasdaq that it had received notices of intention to petition for review of the SEC's July 22, 2026 order approving Nasdaq's proposed rule change requiring listed companies to maintain a minimum Market Value of Listed Securities ("MVLS") of $5 million. Pursuant to Rule 431(e) of the SEC's Rules of Practice, the July 22, 2026 approval order has been stayed pending further review. As discussed in our July 23, 2026 client alert, the approved rule established a new continued listing standard applicable to companies listed on the Nasdaq Capital Market, Nasdaq Global Market and Nasdaq Global Select Market. Under the approved rule, issuers that failed to maintain an MVLS of at least $5 million for 30 consecutive business days would become subject to immediate delisting procedures without the benefit of a traditional cure period. The Effect of the Stay The SEC's July 29, 2026 letter does not reverse or vacate the July 22, 2026 approval of the rule. Rather, it temporarily suspends the effectiveness of that order. According to the SEC, the stay will remain in effect "until the Commission orders otherwise." As a result, the implementation of Nasdaq's new $5 million MVLS continued listing requirement is currently on hold. Until the SEC takes further action, market participants should monitor developments regarding the review process and any subsequent order. Practical Considerations for Nasdaq Issuers Despite the stay, Nasdaq-listed companies that may be affected by the proposed MVLS requirement should continue to evaluate their compliance position and consider the potential impact of the rule should it ultimately become effective. In particular, issuers that may be at risk of falling below the proposed $5 million MVLS requirement should closely monitor whether, if the stay is lifted, any period following the July 22, 2026 approval order will count toward the rule's 30 consecutive business day requirement. We will continue to monitor developments and provide updates as additional information becomes available. For More Information If you would like additional information regarding the SEC's stay of Nasdaq's proposed $5 million MVLS continued listing requirement, the ongoing review process, Nasdaq listing standards generally, or the implications of these developments for your company, please contact the Sullivan & Worcester lawyer with whom you regularly work or any of the attorneys listed below. David Danovitch, Partner (New York) | +1 (212) 660-3060 | ddanovitch@sullivanlaw.com Oded Har-Even, Partner (New York and Tel-Aviv) | +1 (212) 660-3063 | ohareven@sullivanlaw.com Howard Berkenblit, Partner (Boston) | +1 (617) 338-2979 | hberkenblit@sullivanlaw.com Angela Gomes, Partner (Boston) | +1 (617) 338-2957 | agomes@sullivanlaw.com Joseph Segilia, Partner (New York) | +1 (212) 660-3027 | jsegilia@sullivanlaw.com Ron Ben-Bassat, Partner (New York) | +1 (212) 660-5003 | rbenbassat@sullivanlaw.com Eric Victorson, Partner (New York) | +1 (212) 660-3092 | evictorson@sullivanlaw.com Brendan O'Brien, Partner (New York) | +1 (212) 660-3013 | bobrien@sullivanlaw.com Phillip Carnevale, Associate (New York) | +1 (212) 660-3002 | pcarnevale@sullivanlaw.com Elizabeth Johnson, Associate (New York) | +1 (212) 660-3006 | ejohnson@sullivanlaw.com This Client Alert is provided for general informational purposes only and does not constitute legal advice.
Sullivan & Worcester Submits Comment to SEC on Foreign Private Issuer Definition
On September 8, 2025, Sullivan & Worcester submitted a comment letter to the U.S. Securities and Exchange Commission (SEC) in response to Release No. 33-11376; File No. S7-2025-01, which seeks public input on the definition of “foreign private issuer” (FPI) and potential reforms to the framework. The letter, authored by Partners Oded Har-Even, Howard Berkenblit and Eric Victorson, with contributions from Associate Ilana Neck Levin, draws on the firm’s extensive experience advising foreign private issuers, particularly Israeli companies, which comprise a significant portion of the U.S.-listed FPI market. Sullivan’s comments emphasize that the Business Contacts Test should remain the central determinant of FPI status. The letter explains that the shareholder test is often unreliable due to incomplete ownership data, volatility in investor residency and its limited alignment with policy objectives. In contrast, the Business Contacts Test, which focuses on where a company’s management, assets and operations are located, provides a consistent, substance-based standard that has served the markets well for decades. The firm noted that putting too much emphasis on shareholder residency or trading activity could wrongly classify genuine foreign companies as U.S. issuers, creating confusion for investors and making it harder for those companies to raise capital. Instead, Sullivan urged the SEC to keep the current framework in place, making only targeted adjustments where there are clear market concerns.
Sullivan Represents Fattal Hotel Group in Acquisition of The Blakely Hotel in Midtown Manhattan
Sullivan & Worcester represented Fattal Hotel Group, owner and operator of 329 hotels across 22 countries and based in Tel Aviv, in its acquisition and financing of The Blakely Hotel in Midtown Manhattan. The acquisition marks the client's first hotel investment in the United States and is a milestone in its evolution from a leading European hospitality operator into a global hotel group. The acquisition was completed on July 7, 2026. The Sullivan team included Ashley Brooks, Tamir Chagal, Oded Har-Even, Gerry Silver, John Steiner, Nancy Gillman and Ashley Tan. Read more about the transaction here.  
Sullivan Advises Inspira Technologies on Strategic $12.5M Acquisition of Nano Dimension’s AME Platform
Sullivan & Worcester represented Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN), a commercial-stage medical device company, in its acquisition of Nano Dimension’s Additive Manufactured Electronics (AME) platform, a multi-material additive manufacturing platform capable of printing 3D electronic layers with micro-scale precision. The transaction is valued at up to $12.5 million, comprising a $2.0 million upfront cash payment and up to $10.5 million of deferred payments tied to the future performance of the platform over the next twelve months. The Sullivan team involved in the transaction included Oded Har-Even, Reut Alfiah, Tamir Chagal, Shemer Sendak, Ron Ben-Bassat and Shiran Soholitsky. Read the full press release here.

Oded Har-Even

Neural Input Technology Company, Wearable Devices Ltd. IPO

Sullivan represented Wearable Devices Ltd., a growth company developing a non-invasive neural input interface technology in the form of a wrist wearable band for controlling digital devices using subtle finger movements for B2B and B2C customers, in its $16 million initial public offering. Wearable Devices is based in Israel and aims to create a world in which the user’s hand becomes a universal input device for touchlessly interacting with technology, and that their technology is setting the standard input interface for the Metaverse.

Howard E. Berkenblit, Oded Har-Even, Tamilla Nurizada and Ilana Neck Levin

Thermal Energy Storage Company Shares to Commence Trading on Nasdaq

Sullivan advised Brenmiller Energy Ltd., a designer, builder and operator of thermal energy storage systems, in its $15 million private placement of ordinary shares and uplisting of ordinary shares to Nasdaq. The Company develops storage-based generation systems that combines thermal storage, inherent heat exchanging, and inherent steam generation in one unit.

Oded Har-Even, Reut Alfiah, Eric Victorson, Gal Cohen, Ilana Neck Levin and Emily A. Goldschmidt

Solar Panel On Field Against Sky

Oded Har-Even